Lidocaine and other local anesthetics are voltage-gated sodium channel blockers. By blocking these channels, they prevent the rapid influx of sodium ions that is necessary for the rising phase (depolarization) of an action potential. This slows the rate of depolarization and prevents the membrane potential from reaching the threshold required to fire an action potential, thus blocking nerve conduction and sensation.

Incomplete inactivation of voltage-gated sodium channels allows for a persistent influx of positive sodium ions into the neuron after the initial upstroke of the action potential. This sustained inward current opposes the repolarizing outward potassium current, thereby prolonging the period of depolarization. This keeps the neuron in an excited state for longer, facilitating repetitive firing and leading to the hyperexcitability that manifests as seizures.

This clinical presentation is classic for myasthenia gravis, an autoimmune disorder where antibodies target and destroy postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction. The reduction in available receptors means that even with normal acetylcholine release, the resulting end-plate potential is smaller and may fail to reach the threshold for muscle fiber contraction, causing fatigable weakness.

An action potential is triggered when the neuron's membrane potential reaches the threshold of -55 mV. A depolarization of at least 15 mV (from -70 mV) is required. A single EPSP of 10 mV is subthreshold. When Neuron X and Neuron Y fire simultaneously, their individual 10 mV EPSPs summate at the axon hillock (spatial summation). The combined depolarization of 20 mV brings the membrane potential to -50 mV, which is above the threshold, triggering an action potential.

Multiple sclerosis is an autoimmune disease characterized by the destruction of myelin sheaths in the central nervous system. Myelin acts as an electrical insulator, allowing the action potential to propagate rapidly via saltatory conduction, where it 'jumps' between the unmyelinated nodes of Ranvier. When myelin is destroyed, this saltatory conduction is disrupted. The electrical signal dissipates as it travels along the now-uninsulated axon, leading to slowed or completely blocked nerve impulse transmission.

The cardinal motor features of Parkinson's disease (bradykinesia, resting tremor, rigidity) are caused by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc). These neurons project to the striatum (caudate and putamen) as part of the nigrostriatal pathway, which is a critical component of the basal ganglia motor loop responsible for initiating and modulating movement.

Serotonin's action in the synapse is terminated primarily by its reuptake into the presynaptic neuron via the serotonin transporter (SERT). SSRIs, like fluoxetine, selectively block SERT. This inhibition of reuptake prevents serotonin from being cleared from the synaptic cleft, leading to an increased concentration of the neurotransmitter in the cleft. This enhances and prolongs its effect on postsynaptic receptors, which is believed to mediate the drug's antidepressant effects over time.

Organophosphates irreversibly inhibit acetylcholinesterase, causing an excess of acetylcholine at all cholinergic synapses. Muscle fasciculations, followed by paralysis (depolarizing blockade), are characteristic signs of nicotinic receptor overstimulation at the neuromuscular junction. The other symptoms listed—bradycardia, miosis, and excessive salivation—are classic muscarinic effects resulting from overstimulation of the parasympathetic nervous system.

Baclofen is a selective agonist for GABA-B receptors. Unlike GABA-A receptors (which are ligand-gated ion channels), GABA-B receptors are G-protein coupled receptors. Their activation in the spinal cord leads to hyperpolarization of motor neurons by opening potassium channels (increasing K+ efflux) and also inhibits presynaptic calcium influx, which reduces neurotransmitter release. This overall inhibitory effect reduces motor neuron excitability and relieves spasticity.

During ischemia, lack of ATP impairs ion pumps, leading to neuronal depolarization and massive release of the excitatory neurotransmitter glutamate. Glutamate overstimulates its receptors, particularly the NMDA receptor. This leads to a large and sustained influx of calcium (Ca2+). High intracellular Ca2+ is toxic because it activates a cascade of degradative enzymes, including proteases, phospholipases, and endonucleases, ultimately leading to apoptosis and neuronal death.